TY  - GEN
AU  - Guo,Jianxia
AU  - Parise,Robert A
AU  - Joseph,Erin
AU  - Egorin,Merrill J
AU  - Lazo,John S
AU  - Prochownik,Edward V
AU  - Eiseman,Julie L
TI  - Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice
SN  - 1432-0843
PY  - 2009///0331
KW  - Animals
KW  - Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
KW  - antagonists & inhibitors
KW  - Cell Proliferation
KW  - drug effects
KW  - Chromatography, High Pressure Liquid
KW  - Chromatography, Liquid
KW  - Dimerization
KW  - Female
KW  - Humans
KW  - Male
KW  - Mice
KW  - Mice, SCID
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - Proto-Oncogene Proteins c-myc
KW  - Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
KW  - Thiazoles
KW  - pharmacokinetics
KW  - Tissue Distribution
KW  - Treatment Outcome
KW  - Tumor Cells, Cultured
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1007/s00280-008-0774-y
ER  -